Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression

  • 0Center for Infectious Disease Education and Research (CiDER), The University of Osaka, Suita, Osaka, Japan. aharada@cider.osaka-u.ac.jp.

|

|

Summary

This summary is machine-generated.

Wnt5a protein, produced by inflammatory fibroblasts, fuels colon cancer growth by creating a hypoxic tumor microenvironment. Depleting Wnt5a suppresses tumor formation, offering a potential therapeutic target.

Area Of Science

  • Oncology
  • Cell Biology
  • Cancer Research

Background

  • Wnt5a is a Wnt ligand activating β-catenin-independent pathways and promoting tumorigenesis.
  • Its production site and impact on colon cancer aggressiveness remain unclear.

Purpose Of The Study

  • To investigate the source of Wnt5a production in colon cancer.
  • To elucidate the mechanism by which Wnt5a influences colon cancer progression.

Main Methods

  • Meta-analysis of human and mouse colon fibroblast single-cell RNA-seq data.
  • In vivo studies involving Wnt5a depletion in mouse models.
  • Analysis of fibroblast-endothelial cell interactions and molecular signaling pathways.

Main Results

  • Wnt5a is expressed in fibroblasts near the tumor's luminal side, identified as hypoxia-induced inflammatory fibroblasts (InfFib) with activated HIF2.
  • Wnt5a maintains InfFib by suppressing angiogenesis via Flt1 secretion from endothelial cells, inducing hypoxia.
  • InfFib produces epiregulin, promoting colon cancer growth.

Conclusions

  • Wnt5a drives colon cancer progression by inducing a hypoxic microenvironment that sustains InfFib.
  • Targeting Wnt5a or InfFib may represent a novel therapeutic strategy for colon cancer.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply 01:24

2.5K

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Adaptive Mechanisms in Cancer Cells 02:53

5.5K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Canonical Wnt Signaling Pathway 02:54

8.6K

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...

Non-Canonical Wnt Signaling Pathways 01:41

7.2K

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...

Tumor Progression 02:07

6.1K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

The Tumor Microenvironment 02:17

6.4K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...